These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 7594331)
21. Preventive effects of lansoprazole and famotidine on gastric mucosal injury induced by low-dose aspirin in Helicobacter pylori-negative healthy volunteers. Nishino M; Sugimoto M; Kodaira C; Yamade M; Uotani T; Shirai N; Ikuma M; Tanaka T; Sugimura H; Hishida A; Furuta T J Clin Pharmacol; 2011 Jul; 51(7):1079-86. PubMed ID: 20663999 [TBL] [Abstract][Full Text] [Related]
22. The effect of rabeprazole alone or in combination with H2 receptor blocker on intragastric pH: a pilot study. Törüner M; Bektaş M; Cetinkaya H; Soykan I; Ozden A Turk J Gastroenterol; 2004 Dec; 15(4):225-8. PubMed ID: 16249975 [TBL] [Abstract][Full Text] [Related]
23. Comparison of 24-hour intragastric pH using four liquid formulations of lansoprazole and omeprazole. Sharma VK Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S18-21. PubMed ID: 10597120 [TBL] [Abstract][Full Text] [Related]
24. [Effect of a proton pump inhibitor AG-1749 (lansoprazole) on intragastric pH: 24-hour intragastric pH monitoring]. Kihira K; Yoshida Y; Kasano T; Taniguchi Y; Sato K; Kimura K; Hirose M; Koyama H Nihon Shokakibyo Gakkai Zasshi; 1991 Mar; 88(3):672-80. PubMed ID: 1646341 [TBL] [Abstract][Full Text] [Related]
25. [Usefulness of every-other day administration of proton pump inhibitors from the standpoint of continuous 48-hour pH measurements-- Comparison of cimetidine, omeprazole, and lansoprazole]. Yamamoto Y; Sezai S; Sakurabayashi S; Hirano M; Oka H Nihon Shokakibyo Gakkai Zasshi; 1995 Jun; 92(6):919-24. PubMed ID: 7609313 [TBL] [Abstract][Full Text] [Related]
26. Comparison of lansoprazole and famotidine for gastric acid inhibition during the daytime and night-time in different CYP2C19 genotype groups. Shirai N; Furuta T; Xiao F; Kajimura M; Hanai H; Ohashi K; Ishizaki T Aliment Pharmacol Ther; 2002 Apr; 16(4):837-46. PubMed ID: 11929404 [TBL] [Abstract][Full Text] [Related]
27. Twenty-four-hour monitoring of intragastric acidity: comparison between lansoprazole 30mg and pantoprazole 40mg. Florent C; Forestier S Eur J Gastroenterol Hepatol; 1997 Feb; 9(2):195-200. PubMed ID: 9058634 [TBL] [Abstract][Full Text] [Related]
37. The long-lasting effect of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion in dogs. Uchiyama K; Wakatsuki D; Kakinoki B; Takeuchi Y; Araki T; Morinaka Y J Pharm Pharmacol; 1999 Apr; 51(4):457-64. PubMed ID: 10385219 [TBL] [Abstract][Full Text] [Related]
38. Comparison of lansoprazole with omeprazole on 24-hour intragastric pH, acid secretion and serum gastrin in healthy volunteers. Bruley des Varannes S; Levy P; Lartigue S; Dellatolas F; Lemaire M; Galmiche JP Aliment Pharmacol Ther; 1994 Jun; 8(3):309-14. PubMed ID: 7918926 [TBL] [Abstract][Full Text] [Related]
39. Comparison of the effect of lansoprazole and omeprazole on intragastric acidity and gastroesophageal reflux in patients with gastroesophageal reflux disease. Janczewska I; Sagar M; Sjöstedt S; Hammarlund B; Iwarzon M; Seensalu R Scand J Gastroenterol; 1998 Dec; 33(12):1239-43. PubMed ID: 9930385 [TBL] [Abstract][Full Text] [Related]
40. [Effects of intravenous lansoprazole on acute gastric mucosal lesions and acid secretion]. Inatomi N; Murakami I; Asano S; Inada I; Satoh H Nihon Yakurigaku Zasshi; 1996 Dec; 108(6):333-43. PubMed ID: 9017687 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]